Consun Pharmaceutical Group Limited (HKG:1681)
Hong Kong
· Delayed Price · Currency is HKD 15.99
-0.12 (-0.74%)
Apr 29, 2026, 4:08 PM HKT
HKG:1681 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 13,557 | 13,139 | 6,771 | 3,780 | 3,193 | 3,495 | Upgrade
|
| Market Cap Growth | 76.25% | 94.05% | 79.14% | 18.38% | -8.64% | 43.27% | Upgrade
|
| Enterprise Value | 9,787 | 9,318 | 3,788 | 1,258 | 1,225 | 2,132 | Upgrade
|
| Last Close Price | 16.11 | 15.64 | 7.77 | 3.91 | 3.03 | 3.13 | Upgrade
|
| PE Ratio | 11.49 | 10.95 | 6.99 | 4.37 | 4.14 | 4.82 | Upgrade
|
| Forward PE | 9.55 | 9.81 | 6.57 | 4.09 | 4.18 | 3.80 | Upgrade
|
| PS Ratio | 3.57 | 3.46 | 2.14 | 1.33 | 1.21 | 1.39 | Upgrade
|
| PB Ratio | 2.52 | 2.44 | 1.45 | 0.88 | 0.82 | 0.98 | Upgrade
|
| P/TBV Ratio | 2.85 | 2.77 | 1.66 | 1.03 | 1.00 | 1.25 | Upgrade
|
| P/FCF Ratio | - | - | 6.51 | 4.48 | 3.15 | 4.54 | Upgrade
|
| P/OCF Ratio | - | - | 5.85 | 4.19 | 2.98 | 3.92 | Upgrade
|
| PEG Ratio | - | 0.70 | 0.70 | 0.70 | 0.70 | 0.70 | Upgrade
|
| EV/Sales Ratio | 2.57 | 2.45 | 1.20 | 0.44 | 0.46 | 0.85 | Upgrade
|
| EV/EBITDA Ratio | 7.29 | 6.93 | 3.45 | 1.27 | 1.38 | 2.38 | Upgrade
|
| EV/EBIT Ratio | 7.64 | 7.27 | 3.65 | 1.38 | 1.51 | 2.63 | Upgrade
|
| EV/FCF Ratio | - | - | 3.64 | 1.49 | 1.21 | 2.77 | Upgrade
|
| Debt / Equity Ratio | 0.04 | 0.04 | 0.06 | 0.13 | 0.13 | 0.21 | Upgrade
|
| Debt / EBITDA Ratio | 0.18 | 0.18 | 0.26 | 0.57 | 0.58 | 0.83 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.27 | 0.67 | 0.51 | 0.97 | Upgrade
|
| Net Debt / Equity Ratio | -0.76 | -0.76 | -0.82 | -0.78 | -0.75 | -0.62 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.05 | -3.05 | -3.49 | -3.42 | -3.28 | -2.49 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -3.68 | -4.01 | -2.88 | -2.89 | Upgrade
|
| Asset Turnover | 0.56 | 0.56 | 0.52 | 0.50 | 0.51 | 0.49 | Upgrade
|
| Inventory Turnover | 2.42 | 2.42 | 2.07 | 1.99 | 2.12 | 2.13 | Upgrade
|
| Quick Ratio | 2.98 | 2.98 | 3.09 | 2.60 | 2.47 | 2.06 | Upgrade
|
| Current Ratio | 3.22 | 3.22 | 3.32 | 2.86 | 2.68 | 2.25 | Upgrade
|
| Return on Equity (ROE) | 23.60% | 23.60% | 22.07% | 21.38% | 21.53% | 21.64% | Upgrade
|
| Return on Assets (ROA) | 11.74% | 11.74% | 10.73% | 9.93% | 9.66% | 9.93% | Upgrade
|
| Return on Invested Capital (ROIC) | 91.41% | 108.02% | 106.82% | 88.13% | 67.03% | 50.16% | Upgrade
|
| Return on Capital Employed (ROCE) | 23.10% | 23.10% | 21.80% | 20.60% | 20.20% | 22.00% | Upgrade
|
| Earnings Yield | 8.85% | 9.13% | 14.31% | 22.87% | 24.18% | 20.73% | Upgrade
|
| FCF Yield | - | - | 15.37% | 22.34% | 31.73% | 22.03% | Upgrade
|
| Dividend Yield | 4.97% | 4.67% | 7.72% | 11.52% | 9.90% | 9.58% | Upgrade
|
| Payout Ratio | - | - | 74.75% | 41.59% | 18.67% | 33.56% | Upgrade
|
| Buyback Yield / Dilution | -2.77% | -2.77% | -4.12% | -0.91% | 1.58% | 1.54% | Upgrade
|
| Total Shareholder Return | 2.32% | 1.90% | 3.60% | 10.62% | 11.48% | 11.12% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.